secwatch / observer

8-K filed February 26, 2026, 6:59 PM ET ticker ACAA CIK 0002096900

other material confidence high sentiment neutral materiality 0.50

Averin Capital Acquisition Corp. closes $250M IPO and private placement; trust funded

Averin Capital Acquisition Corp.

Closed IPO of 25M units at $10.00/unit for gross proceeds of $250M; each unit consists of one Class A ordinary share and 1/6 warrant.
Sponsor purchased 200,000 private placement units at $10.00/unit, gross proceeds of $2M.
$250M deposited into trust account ($10.00 per unit) with Continental Stock Transfer & Trust as trustee.
Audited balance sheet as of Feb 20, 2026: total assets $250.7M, trust $250M, shareholders' deficit $13.4M.
Auditor's report includes going concern doubt due to significant costs in pursuit of acquisition plans.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-020798
form_type: 8-K
ticker: ACAA
cik: 0002096900
company_name: Averin Capital Acquisition Corp.
filed_at: 2026-02-26T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.252088+00:00
generated_at: 2026-05-15T23:53:41.444879+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-020798
json_url: https://secwatch.observer/filing/0001213900-26-020798.json
markdown_url: https://secwatch.observer/filing/0001213900-26-020798.md
text_url: https://secwatch.observer/filing/0001213900-26-020798.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2096900/000121390026020798/0001213900-26-020798-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2096900/000121390026020798/ea0277921-8k_averin.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

GIPR

Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit

GENERATION INCOME PROPERTIES, INC. June 1, 2026, 5:27 PM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MUX

McEwen receives $49.4M dividend from Minera Santa Cruz; total 2026 dividends now $58.2M

McEwen Inc. June 1, 2026, 5:14 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EMYB

Embassy Bancorp expands stock repurchase program by additional $5M

Embassy Bancorp, Inc. June 1, 2026, 4:37 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTXR

Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned

Citius Pharmaceuticals, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTOR

Citius Oncology reports Phase 1 combo data for LYMPHIR in gynecologic cancers; 24% ORR, 33% in endometrial cancer

CITIUS ONCOLOGY, INC. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SYRE

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ORKA

Oruka Therapeutics expands ORKA-001 license to include IBD; clinical dosing restrictions until 2028-2030

Oruka Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Via Renewables to redeem all 1,884,935 shares of its 8.75% Series A Preferred at $25.00 per share plus dividends

Via Renewables, Inc. June 1, 2026, 3:06 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-26-020798

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.